BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23844138)

  • 1. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
    Yamaguchi K; Matsumoto T; Kuwata K
    Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
    Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
    Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein mPrP[F175A](121-231): structure and stability in solution.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2012 Nov; 423(4):496-502. PubMed ID: 22922482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
    Tahiri-Alaoui A; James W
    Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization.
    Hornemann S; Korth C; Oesch B; Riek R; Wider G; Wüthrich K; Glockshuber R
    FEBS Lett; 1997 Aug; 413(2):277-81. PubMed ID: 9280297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segments in the Amyloid Core that Distinguish Hamster from Mouse Prion Fibrils.
    Shen HC; Chen YH; Lin YS; Chu BK; Liang CS; Yang CC; Chen RP
    Neurochem Res; 2019 Jun; 44(6):1399-1409. PubMed ID: 30603982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.